Revelar Appoints Linda McAllister as Chief Medical Officer

Revelar Health, an innovative company developing a near-patient device that accurately measures aldehyde concentrations with a simple breath test, has named Linda McAllister, M.D., Ph.D. the company’s Chief Medical Officer (CMO).

PORTLAND, Ore. (PRWEB) April 17, 2018

Revelar Health, an innovative company developing a near-patient device that accurately measures aldehyde concentrations with a simple breath test, has named Linda McAllister, M.D., Ph.D. the company’s Chief Medical Officer (CMO).

“We’re extremely excited to have Linda on board,” said Chris Marsh, CEO and President of Revelar. “As we navigate future product opportunities, clinical research, and partnerships, Linda’s expertise and energy are incredibly valuable to our fast-growing company. Her experience in medical devices and diagnostics make her a perfect addition to the team and advances our position in breath science.”

Before joining Revelar, Dr. McAllister was VP of Scientific Affairs and Innovation at Becton Dickinson. Previous to that role, she advised multiple early-stage device and diagnostic companies. Prior to consulting, Dr. McAllister held CMO positions at Xagenic, CellScape, PharmaJet, and Arbor Vita Corp. Prior to Arbor Vita Corp, Dr. McAllister held Director positions at Roche Diagnostics and Celera. Prior to Celera, she was Scientific Liaison, Program Manager for Genotyping at Affymetrix.

“Revelar’s innovation brings complex chemistry to the point of care — and offers the potential to greatly enable metabolomics in detecting and monitoring a wide range of clinical conditions,” Dr. McAllister said.

Dr. McAllister received her B.S. in Biology and Chemistry from the California Institute of Technology (Caltech), where she conducted her research under the guidance of two Nobel Laureates. She received her Ph.D. in Neuroscience and M.D. from Stanford University Medical School. Dr. McAllister completed her residency in internal medicine at the UCSF Hospital and was a Bugher Cardiovascular Research Fellow at Stanford working on the first DNA microarrays. Linda also practiced medicine part time for ten years as a clinical faculty member at UCSF.

Headquartered in Portland, OR, Revelar is a leading breath science company focused on measuring and analyzing key biomarkers in point-of-care settings to provide critical data points and accelerate efficacy in disease prevention, detection, and personalized treatment protocols.

For the original version on PRWeb visit: http://www.prweb.com/releases/2018/04/prweb15415991.htm